Table 1 Patient characteristics
| Â | All patients | Glioblastoma | WHO grade III | PCNSL | MBT | WHO grade I |
|---|---|---|---|---|---|---|
n = 76 | n = 21 | n = 10 | n = 10 | n = 9 | n = 26 | |
Sex, n (%) | ||||||
  Male | 45 (59) | 15 (71) | 6 (60) | 5 (50) | 8 (89) | 11 (42) |
  Female | 31 (41) | 6 (29) | 4 (40) | 5 (50) | 1 (11) | 15 (58) |
Age, years, mean ± SD | 61.1 ± 12.5 | 58.7 ± 10.8 | 55.6 ± 11.7 | 64.5 ± 10.3 | 67.0 ± 9.5 | 61.8 ± 15.1 |
Tumor histology, n | Â | Â | Anaplastic astrocytoma 4 | Â | Â | Meningioma 15 |
| Â | Â | Â | Anaplastic oligodendroglioma 2 | Â | Â | Schwannoma 6 |
| Â | Â | Â | Anaplastic pleomorphic xanthoastrocytoma 2 | Â | Â | Pituitary adenoma 2 |
| Â | Â | Â | Anaplastic ependymoma 1 | Â | Â | Hemangioblastoma 2 |
| Â | Â | Â | NOS 1 | Â | Â | Craniopharyngioma 1 |
KPS, mean ± SD | 86.3 ± 13.5 | 84.8 ± 15.7 | 77.0 ± 12.5 | 92.0 ± 10.3 | 90.0 ± 7.1 | 87.7 ± 13.4 |
Tumor location, n (%) | Â | Â | Â | Â | Â | Â |
  Right | 27 (35) | 10 (48) | 6 (60) | 5 (50) | 3 (33) | 3 (12) |
  Left | 21 (28) | 9 (43) | 3 (30) | 2 (20) | 3 (33) | 4 (15) |
  Both/other | 28 (37) | 2 (9) | 1 (10) | 3 (30) | 3 (33) | 19 (73) |
Treatment, n (%) | Â | Â | Â | Â | Â | Â |
  Surgical resection | 59 (78) | 17 (81) | 7 (70) | 0 (0) | 9 (100) | 26 (100) |
  Radiation | 34 (45) | 15 (71) | 7 (70) | 4 (40) | 8 (89) | 0 (0) |
  Chemotherapy | 38 (50) | 20 (95) | 9 (90) | 8 (80) | 1 (11) | 0 (0) |
Recurrence, n (%) | Â | Â | Â | Â | Â | Â |
  Yes | 20 (26) | 8 (38) | 5 (50) | 3 (30) | 0 (0) | 4 (15) |
  No | 56 (74) | 13 (62) | 5 (50) | 7 (70) | 9 (100) | 22 (85) |
Discharge disposition, n (%) | Â | Â | Â | Â | Â | Â |
  Discharged home | 60 (79) | 16 (76) | 7 (70) | 9 (90) | 7 (78) | 21 (81) |
  Transfer to a different hospital | 16 (21) | 5 (24) | 3 (30) | 1 (10) | 2 (22) | 5 (19) |